|
⚲
|
| Keyboard |
| Rock Edwin
✚
|
|
|---|---|
| CIK # | 0001945417 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001945417] | |
| 4 | [0001945417] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rock Edwin | |
| Crescent Biopharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-06-21 | Buy | 115,000 | $0.27 | 31,050 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2024-06-20 | Buy | 190,000 | $0.25 | 47,500 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2024-01-12 | Grant | 250,000 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2023-09-22 | Buy | 30,403 | $1.38 | 41,956 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2023-09-21 | Buy | 35,000 | $1.38 | 48,300 |
|
Crescent Biopharma Inc GLYC
Employee Stock Option (right to buy) · derivative
|
2023-01-19 | Grant | 244,800 | $0.00 | |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2022-12-22 | Buy | 110,000 | $2.25 | 247,500 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2022-11-15 | Buy | 100,000 | $1.66 | 166,000 |
|
Crescent Biopharma Inc GLYC
Common Stock
|
2022-11-14 | Buy | 100,000 | $1.43 | 143,000 |
|
Crescent Biopharma Inc GLYC
Employee stock option (right to buy) · derivative
|
2022-09-02 | Grant | 200,000 | $0.00 |